Laurence Picon

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

Édouard Louis, Jean–Yves Mary, Gwénola Vernier-Massouille et al. · Gastroenterology · 2011 · 589 citations · Full text

Inflammation, Antimetabolite Therapy, Anti-inflammatory +5

Infliximab Plus Azathioprine for Steroid-Dependent Crohn’s Disease Patients: A Randomized Placebo-Controlled Trial

Marc Lémann, Jean–Yves Mary, Bernard Duclos et al. · Gastroenterology · 2006 · 370 citations

Inflammation, Anti-inflammatory, Infliximab Plus Azathioprine +6

Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study

Yoram Bouhnik, Franck Carbonnel, David Laharie et al. · Gut · 2017 · 315 citations · Full text

Alterations in the Intestinal Microbiome (Dysbiosis) as a Predictor of Relapse After Infliximab Withdrawal in Crohnʼs Disease

Sylvie Rajca, Virginie Grondin, Édouard Louis et al. · Inflammatory Bowel Diseases · 2014 · 234 citations · Full text

Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease

Aurélien Amiot, Jean–Charles Grimaud, Laurent Peyrin‐Biroulet et al. · Clinical Gastroenterology and Hepatology · 2016 · 189 citations

Inflammation, Anti-inflammatory, Immunology +6